Grail publishes presentation on blood-based detection of liver and bile duct cancers

GRAL•2026-11-07

Grail published a research presentation evaluating targeted ctDNA methylation profiling for liver and biliary tract cancers. The blood test detected cancer signals in 86% to 95% of samples from 657 patients across three phase 3 trials.

Grail publishes presentation on blood-based detection of liver and bile duct cancers

1. Study findings

Related News

Sprouts Farmers Market CEO Jack Sinclair reports $1.14 million share sale

Alaska high court revives opioid lawsuit against pharmacy operators

Knight-Swift names Richard Andrew Howard to board

Sources

Grail publishes presentation on blood-based detection of liver and bile duct cancers

Logitech study finds 94% of leaders say workplace experience failures hit bottom line

Trial failures of Novartis and Novo Nordisk heart drugs leave experts guessing